Просмотреть запись

Outcomes of Patients With Hypertrophic Obstructive Cardiomyopathy and Pacemaker Implanted After Alcohol Septal Ablation

Электронный научный архив УРФУ

Информация об архиве | Просмотр оригинала
 
 
Поле Значение
 
Заглавие Outcomes of Patients With Hypertrophic Obstructive Cardiomyopathy and Pacemaker Implanted After Alcohol Septal Ablation
 
Автор Veselka, J.
Liebregts, M.
Cooper, R.
Faber, L.
Januska, J.
Kashtanov, M.
Tesarkova, K. H.
Hansen, P. R.
Seggewiss, H.
Shloydo, E.
Popov, K.
Hansvenclova, E.
Bonaventura, J.
Berg, J. T.
Stables, R. H.
Polakova, E.
 
Тематика ALCOHOL SEPTAL ABLATION
PERMANENT PACEMAKER
PROGNOSIS
ABLATION TECHNIQUES
ATRIOVENTRICULAR BLOCK
CARDIOMYOPATHY, HYPERTROPHIC
ETHANOL
HEART SEPTUM
HUMANS
PACEMAKER, ARTIFICIAL
RETROSPECTIVE STUDIES
TREATMENT OUTCOME
ALCOHOL
ADULT
ALCOHOL SEPTAL ABLATION
ALL CAUSE MORTALITY
ARTICLE
ATRIOVENTRICULAR BLOCK
CLINICAL EXAMINATION
COHORT ANALYSIS
CONTROLLED STUDY
FEMALE
FOLLOW UP
HEART BUNDLE BRANCH BLOCK
HEART LEFT VENTRICLE EJECTION FRACTION
HUMAN
HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
INTERVENTRICULAR SEPTUM
MAJOR CLINICAL STUDY
MALE
MIDDLE AGED
MUSCLE RESECTION
NEW YORK HEART ASSOCIATION CLASS
OUTCOME ASSESSMENT
PACEMAKER IMPLANTATION
PROPENSITY SCORE
SHARED DECISION MAKING
SUDDEN CARDIAC DEATH
ABLATION THERAPY
ADVERSE EVENT
ARTIFICIAL HEART PACEMAKER
ATRIOVENTRICULAR BLOCK
DIAGNOSTIC IMAGING
HEART SEPTUM
HYPERTROPHIC CARDIOMYOPATHY
RETROSPECTIVE STUDY
TREATMENT OUTCOME
 
Описание Background: Atrioventricular block is a frequent major complication after alcohol septal ablation (ASA). Objectives: The aim of this study was to evaluate the outcomes of patients with implanted permanent pacemaker (PPM) related to a high-grade atrioventricular block after ASA for hypertrophic obstructive cardiomyopathy. Methods: We used a multinational registry (the Euro-ASA registry) to evaluate the outcome of patients with PPM after ASA. Results: A total of 1,814 patients were enrolled and followed up for 5.0 ± 4.3 years (median = 4.0 years). A total of 170 (9.4%) patients underwent PPM implantation during the first 30 days after ASA. Using propensity score matching, 139 pairs (n = 278) constituted the matched PPM and non-PPM groups. Between the matched groups, there were no long-term differences in New York Heart Association functional class (1.5 ± 0.7 vs 1.5 ± 0.9, P = 0.99) and survival (log-rank P = 0.47). Patients in the matched PPM group had lower long-term left ventricular (LV) outflow gradient (12 ± 12 mm Hg vs 17 ± 19 mm Hg, P < 0.01), more pronounced LV outflow gradient decrease (81% ± 17% vs 72% ± 35%, P < 0.01), and lower LV ejection fraction (64% ± 8% vs 66% ± 8%, P = 0.02) and were less likely to undergo reintervention (re-ASA or myectomy) (log-rank P = 0.02). Conclusions: Patients with hypertrophic obstructive cardiomyopathy treated with ASA have a 9% probability of PPM implantation within 30 days after ASA. In long-term follow-up, patients with PPM had similar long-term survival and New York Heart Association functional class but lower LV outflow gradient, a more pronounced LV outflow gradient decrease, a lower LV ejection fraction, and a lower likelihood of reintervention compared with patients without PPM. © 2022 American College of Cardiology Foundation
 
Дата 2024-04-22T15:53:44Z
2024-04-22T15:53:44Z
2022
 
Тип Article
Journal article (info:eu-repo/semantics/article)
Published version (info:eu-repo/semantics/publishedVersion)
 
Идентификатор Veselka, J, Liebregts, M, Cooper, R, Faber, L, Januska, J, Kashtanov, M, Tesarkova, KH, Hansen, PR, Seggewiss, H, Shloydo, E, Popov, K, Hansvenclova, E, Bonaventura, J, Berg, JT, Stables, RH & Polakova, E 2022, 'Outcomes of Patients With Hypertrophic Obstructive Cardiomyopathy and Pacemaker Implanted After Alcohol Septal Ablation', JACC: Cardiovascular Interventions, Том. 15, № 19, стр. 1910-1917. https://doi.org/10.1016/j.jcin.2022.06.034
Veselka, J., Liebregts, M., Cooper, R., Faber, L., Januska, J., Kashtanov, M., Tesarkova, K. H., Hansen, P. R., Seggewiss, H., Shloydo, E., Popov, K., Hansvenclova, E., Bonaventura, J., Berg, J. T., Stables, R. H., & Polakova, E. (2022). Outcomes of Patients With Hypertrophic Obstructive Cardiomyopathy and Pacemaker Implanted After Alcohol Septal Ablation. JACC: Cardiovascular Interventions, 15(19), 1910-1917. https://doi.org/10.1016/j.jcin.2022.06.034
1936-8798
Final
All Open Access; Bronze Open Access
https://doi.org/10.1016/j.jcin.2022.06.034
https://doi.org/10.1016/j.jcin.2022.06.034
http://elar.urfu.ru/handle/10995/132486
10.1016/j.jcin.2022.06.034
85138367372
879070600005
 
Язык en
 
Права Open access (info:eu-repo/semantics/openAccess)
publisher-specific-oa
 
Формат application/pdf
 
Издатель Elsevier Inc.
 
Источник JACC: Cardiovascular Interventions
JACC: Cardiovascular Interventions